MAP2K7 and melanoma: However, no hypothesis can be suggested in this case, since this is considered a very rare BRAF mutation and very little is known about its associated intracellular signaling alterations; it has actually been reported that, in melanoma cells, BRAF mutations can be associated to different intracellular pathways, in addition to the MEK/ERK cascade [75].